KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Debt to Equity (2016 - 2025)

Johnson & Johnson's Debt to Equity history spans 17 years, with the latest figure at $0.59 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 14.71% year-over-year to $0.59; the TTM value through Dec 2025 reached $0.59, up 14.71%, while the annual FY2025 figure was $0.59, 14.71% up from the prior year.
  • Debt to Equity for Q4 2025 was $0.59 at Johnson & Johnson, down from $0.65 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.75 in Q2 2023 and bottomed at $0.42 in Q4 2023.
  • The 5-year median for Debt to Equity is $0.51 (2021), against an average of $0.52.
  • The largest annual shift saw Debt to Equity surged 147.48% in 2021 before it plummeted 35.66% in 2024.
  • A 5-year view of Debt to Equity shows it stood at $0.48 in 2021, then fell by 11.08% to $0.43 in 2022, then fell by 0.66% to $0.43 in 2023, then increased by 20.15% to $0.51 in 2024, then rose by 14.71% to $0.59 in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Debt to Equity are $0.59 (Q4 2025), $0.65 (Q2 2025), and $0.67 (Q1 2025).